These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33896708)

  • 1. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico.
    Avila-Nava A; Cortes-Telles A; Torres-Erazo D; López-Romero S; Chim Aké R; Gutiérrez Solis AL
    Cytokine; 2021 Jul; 143():155543. PubMed ID: 33896708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
    Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
    Front Immunol; 2021; 12():745515. PubMed ID: 34858403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.
    Gorham J; Moreau A; Corazza F; Peluso L; Ponthieux F; Talamonti M; Izzi A; Nagant C; Ndieugnou Djangang N; Garufi A; Creteur J; Taccone FS
    PLoS One; 2020; 15(12):e0244628. PubMed ID: 33382773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity.
    Tang Y; Sun J; Pan H; Yao F; Yuan Y; Zeng M; Ye G; Yang G; Zheng B; Fan J; Pan Y; Zhao Z; Guo S; Liu Y; Liao F; Duan Y; Jiao X; Li Y
    Cytokine; 2021 Jul; 143():155523. PubMed ID: 33840589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
    Udomsinprasert W; Jittikoon J; Sangroongruangsri S; Chaikledkaew U
    J Clin Immunol; 2021 Jan; 41(1):11-22. PubMed ID: 33128665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.
    Santa Cruz A; Mendes-Frias A; Oliveira AI; Dias L; Matos AR; Carvalho A; Capela C; Pedrosa J; Castro AG; Silvestre R
    Front Immunol; 2021; 12():613422. PubMed ID: 33679753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19.
    Luporini RL; Rodolpho JMA; Kubota LT; Martin ACBM; Cominetti MR; Anibal FF; Pott-Junior H
    Cytokine; 2021 Jul; 143():155507. PubMed ID: 33839002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients.
    Mortaz E; Tabarsi P; Jamaati H; Dalil Roofchayee N; Dezfuli NK; Hashemian SM; Moniri A; Marjani M; Malekmohammad M; Mansouri D; Varahram M; Folkerts G; Adcock IM
    Front Immunol; 2021; 12():592727. PubMed ID: 33968010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
    Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
    mBio; 2021 May; 12(3):. PubMed ID: 33947753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
    Bülow Anderberg S; Luther T; Berglund M; Larsson R; Rubertsson S; Lipcsey M; Larsson A; Frithiof R; Hultström M
    Cytokine; 2021 Feb; 138():155389. PubMed ID: 33348065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More Evidence of the Link of Interleukin-6 and Interleukin-10 with Critical COVID-19: A Report in Mexican Patients.
    Jiménez-Gastélum GR; Espinoza-Ortega AM; Ramos-Payán R; Aguilar-Medina M; López-Gutiérrez J; Villegas-Mercado C; Ochoa-Ramírez LA; Rendón-Aguilar H; Osuna-Ramos JF; Ríos-Tostado JJ; Velarde-Félix JS
    Iran J Immunol; 2021 Dec; 18(4):331-337. PubMed ID: 34931618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of artificial liver blood purification treatment on the survival of critical ill COVID-19 patients.
    Dai X; Zhang Y; Yu L; Jiang YA; Chen L; Chen Y; Li M; Gao C; Shang J; Xiang S; Li Y; Li J; Zhou C; Zhou X; Chen N; Liu Y; Liu J; Zhang Y; Chen X; Zhu D; Gao H; Tang L; Zhu M; Li L
    Artif Organs; 2021 Jul; 45(7):762-769. PubMed ID: 33326621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
    Copaescu A; James F; Mouhtouris E; Vogrin S; Smibert OC; Gordon CL; Drewett G; Holmes NE; Trubiano JA
    Front Immunol; 2021; 12():646095. PubMed ID: 33815405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2.
    Li X; Liu Y; Li J; Sun L; Yang J; Xu F; Zhou J; Wan L; Xu X; Le A; Zhang W
    Immunol Res; 2020 Dec; 68(6):398-404. PubMed ID: 32989677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19.
    Qu R; Ling Y; Zhang YH; Wei LY; Chen X; Li XM; Liu XY; Liu HM; Guo Z; Ren H; Wang Q
    J Med Virol; 2020 Sep; 92(9):1533-1541. PubMed ID: 32181903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.